Clinical

Dataset Information

Establishment and validation of therapeutic effect prediction model of first line treatment of bevacizumab combined with mFOLFOX6 in Ras mutant colorectal cancer patients with liver metastasis


ABSTRACT: Interventions: Gold Standard:Clinical outcome;Index test:Therapeutic effect prediction model of first line treatment of bevacizumab combined with mFOLFOX6 in Ras mutant colorectal cancer patients with liver metastasis Primary outcome(s): Objective response rate;SEN, SPE, ACC, AUC of ROC, PPV, NPV Study Design: Sequential

DISEASE(S): Colorectal Cancer

PROVIDER: 2696954 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR